Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Knight Therapeutics Inc. (T.GUD) had Return on Investments of -1.49% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-9.12M |
|
-- |
|
-- |
|
-- |
|
-2.65M |
|
-- |
|
-11.28M |
|
-11.28M |
|
-9.12M |
|
-9.12M |
|
-9.12M |
|
-9.12M |
|
-2.65M |
|
6.12M |
|
99.63M |
|
99.63M |
|
-0.09 |
|
-0.09 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
750.30M |
|
-- |
|
-- |
|
-- |
|
198.71M |
|
551.59M |
|
208.30M |
|
551.59M |
|
99.65M |
|
| Cash Flow Statement Financials | |
17.29M |
|
-50.00M |
|
33.33M |
|
57.91M |
|
56.25M |
|
-1.66M |
|
2.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.47 |
|
-- |
|
-- |
|
0.10 |
|
0.14 |
|
41.76% |
|
-3.42% |
|
-3.42% |
|
-- |
|
-14.54% |
|
-11.76% |
|
16.60M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.42 |
|
1.00 |
|
90.29 |
|
-1.65% |
|
-4.38% |
|
-1.22% |
|
|
Return on Investments |
-1.49% |
7.66 |
|
0.17 |
|
0.17 |
|